BPG is committed to discovery and dissemination of knowledge
Case Report
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. May 16, 2022; 10(14): 4676-4683
Published online May 16, 2022. doi: 10.12998/wjcc.v10.i14.4676
Cutaneous metastasis from esophageal squamous cell carcinoma: A case report
Rui-Yan Zhang, Shi-Jie Zhu, Peng Xue, Sheng-Qi He
Rui-Yan Zhang, Shi-Jie Zhu, Peng Xue, Sheng-Qi He, Department of Oncology, Wangjing Hospital, China Academy of Chinese Medicine Sciences, Beijing 100102, China
Author contributions: Xue P and He SQ were the patient’s oncologists, reviewed the literature and contributed to manuscript drafting; Zhang RY interpreted the imaging and pathology pictures, reviewed the literature and contributed to manuscript drafting; Zhu SJ and He SQ were responsible for the revision of the manuscript for important intellectual content; All authors issued final approval for the version to be submitted.
Informed consent statement: Treatment consent has been obtained.
Conflict-of-interest statement: The authors have no potential conflicts of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Sheng-Qi He, MM, Associate Chief Physician, Department of Oncology, Wangjing Hospital, China Academy of Chinese Medicine Sciences, No. 6 South Central Road, Wangjing Street, Chaoyang District, Beijing 100102, China. heshengqi@sina.com
Received: November 27, 2021
Peer-review started: November 27, 2021
First decision: January 12, 2022
Revised: January 27, 2022
Accepted: March 16, 2022
Article in press: March 16, 2022
Published online: May 16, 2022
Processing time: 167 Days and 2.5 Hours
Core Tip

Core Tip: Cutaneous metastasis from esophageal carcinoma is rare, especially esophageal squamous cell carcinoma. We present a patient with squamous cell carcinoma of the esophagus and metastasis to diffuse cutaneous tissue. Second-line chemotherapy and immunological checkpoint inhibitor treatment were not effective, and this patient only achieved a 4-mo survival time after cutaneous metastasis.